Diagnosis of Gastric Cancer by Serum Proteomic Fingerprinting
Open Access
- 31 May 2006
- journal article
- research article
- Published by Elsevier BV in Gastroenterology
- Vol. 130 (6), 1858-1864
- https://doi.org/10.1053/j.gastro.2006.02.011
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Prediction of Liver Fibrosis and Cirrhosis in Chronic Hepatitis B Infection by Serum Proteomic Fingerprinting: A Pilot StudyClinical Chemistry, 2005
- Serial Analysis of Plasma Proteomic Signatures in Pediatric Patients with Severe Acute Respiratory Syndrome and Correlation with Viral LoadClinical Chemistry, 2004
- Screening for gastric cancer: does it make sense?Alimentary Pharmacology & Therapeutics, 2004
- Comprehensive Proteomic Profiling Identifies Serum Proteomic Signatures for Detection of Hepatocellular Carcinoma and Its SubtypesClinical Chemistry, 2003
- Use of proteomic patterns in serum to identify ovarian cancerThe Lancet, 2002
- Significance analysis of microarrays applied to the ionizing radiation responseProceedings of the National Academy of Sciences of the United States of America, 2001
- Clinical Importance of Preoperative Carcinoembryonic Antigen and Carbohydrate Antigen 19-9 Levels in Gastric CancerJournal of Clinical Gastroenterology, 2001
- Clinical utility of CEA, CA 19-9, and CA 72-4 in the follow-up of patients with resectable gastric cancerThe American Journal of Surgery, 2001
- Prognostic value of carcinoembryonic antigen, CA 19-9 and CA 72-4 in gastric carcinoma.Tumor Biology, 2001
- Prognostic Significance of CEA, CA 19-9 and CA 72-4 Preoperative Serum Levels in Gastric CarcinomaOncology, 1999